A Digital-First approach to Medical Weight Management The conventional methods of weight-loss treatment tend to be based on physical clinic sessions, specialist recommendations, and long queues
Modulatory effects of the peptide BPC 157 on muscle healing and muscle function improvement
Building on these research findings, Eli Lilly developed a dual agonist targeting GLP-1R/GIPR, called tirzepatide, which was approved by the FDA in 2022 and showed promising therapeutic effects for T2D and obesity
It is worth being precise about what a Phase 2 trial can and cannot establish
These sample protocols provide starting frameworks adaptable to individual needs
Two to three resistance training sessions per week, using body weight exercises, resistance bands, or light weights, can substantially reduce muscle loss during weight loss